[1] |
Gastelum ZN, Biggs DM, Scott A . Multiple myeloma presenting as acute renal failure in the absence of other characteristic features[J]. Cureus, 2017,9(9):e1703.DOI: 10.7759/cureus.1703.
doi: 10.7759/cureus.1703
|
[2] |
Chim CS, Kumar SK, Orlowski RZ , et al. Management of relapsed and refractory multiple myeloma:novel agents,antibodies,immunotherapies and beyond[J]. Leukemia, 2018,32(2):252-262.DOI: 10.1038/leu.2017.329.
doi: 10.1038/leu.2017.329
pmid: 29257139
|
[3] |
Kubiczkova L, Pour L, Sedlarikova L , et al. Proteasome inhibitors-molecular basis and current perspectives in multiple myeloma[J]. J Cell Mol Med, 2014,18(6):947-961.DOI: 10.1111/jcmm.12279.
doi: 10.1111/jcmm.12279
pmid: 4508135
|
[4] |
Raje N, Hideshima T, Anderson KC . Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma[J]. Expert Rev Anticancer Ther, 2006,6(9):1239-1247.DOI: 10.1586/14737140.6.9.1239.
doi: 10.1586/14737140.6.9.1239
|
[5] |
Chen DH, Zhang XS . Targeted therapy:resistance and re-sensitization[J]. Chin J Cancer, 2015,34(11):496-501.DOI: 10.1186/s40880-015-0047-1.
doi: 10.1186/s40880-015-0047-1
pmid: 4593385
|
[6] |
Oerlemans R, Franke NE, Assaraf YG , et al. Molecular basis of bortezomib resistance:proteasome subunit beta5(PSMB5)gene mutation and overexpression of PSMB5 protein[J]. Blood, 2008,112(6):2489-2499.DOI: 10.1182/blood-2007-08-104950.
doi: 10.1182/blood-2007-08-104950
pmid: 18565852
|
[7] |
Lindstr?m MS, Nistér M . Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation[J]. PLoS One, 2010,5(3):e9578.DOI: 10.1371/journal.pone.0009578.
doi: 10.1371/journal.pone.0009578
|
[8] |
Roy P, Sarkar U, Basak S . The NF-κB activating pathways in multiple myeloma[J]. Biomedicines, 2018,6(2):59.DOI: 10.3390/biomedicines6020059.
doi: 10.3390/biomedicines6020059
|
[9] |
吴丽明, 王少元, 王少雄 , 等. 核糖体蛋白RPL36A siRNA对U937细胞的促增殖、抑凋亡作用[J]. 中国实验血液学杂志, 2010,18(2):344-349.DOI: 1009-2137(2010)02-0344-06.
doi: 1009-2137(2010)02-0344-06
|
[10] |
Lim KH, Kim KH, Choi SI , et al. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function[J]. PLoS One, 2011,6(8):e22258.DOI: 10.1371/journal.pone.0022258.
doi: 10.1371/journal.pone.0022258
|
[11] |
McFarland CD, Yaglom JA, Wojtkowiak JW , et al. The damaging effect of passenger mutations on cancer progression[J]. Cancer Res, 2017,77(18):4763-4772.DOI: 10.1158/0008-5472.CAN-15-3283-T.
doi: 10.1158/0008-5472.CAN-15-3283-T
|
[12] |
Tsai CY, Li FCH, Wu CHY , et al. Sumoylation of IkB attenuates NF-kB-induced nitrosative stress at rostral ventrolateral medulla and cardiovascular depression in experimental brain death[J]. J Biomed Sci, 2016,23:65.DOI: 10.1186/s12929-016-0283-y.
doi: 10.1186/s12929-016-0283-y
pmid: 5034413
|